SCHEMBL10126523

SCHEMBL10126523

Cc1ccc(N(c2ccc(C)cc2)c2ccc(NCCCBr)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.53
HTT P42858 1/20 0.37
ALDH1A1 P00352 4/20 0.37
MEN1 O00255 2/20 0.37
GAA P10253 2/20 0.37
KMT2A Q03164 2/20 0.37
PTPN1 P18031 1/20 0.36
HRH3 Q9Y5N1 1/20 0.36
RAB9A P51151 2/20 0.36
POLB P06746 2/20 0.35
KDM4E B2RXH2 1/20 0.35
HSP90AA1 P07900 1/20 0.35
HSP90AB1 P08238 1/20 0.35
THRB P10828 1/20 0.35
HPGD P15428 1/20 0.35
ALOX15 P16050 1/20 0.35
MAPK1 P28482 1/20 0.35
CASP1 P29466 1/20 0.35
BLM P54132 1/20 0.35
PLEC Q15149 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19634902 0.89 MAPT (0.67) MAPTHTTALDH1A1MEN1GAA
SCHEMBL21183218 0.86 MAPT (0.57) MAPTHTTALDH1A1MEN1GAA
SCHEMBL7398270 0.77 MAPT (0.73) MAPTHTTALDH1A1MEN1GAA
SCHEMBL10416186 0.77 ALDH1A1 (0.53) MAPTHTTALDH1A1MEN1GAA
SCHEMBL11518048 0.77 MAPT (0.80) MAPTHTTALDH1A1MEN1GAA
SCHEMBL8648413 0.76 ABL1 (0.49) MAPTALDH1A1HRH3RAB9AKDM4E
SCHEMBL22139553 0.75 MAPT (0.44) MAPTGAAHRH3RAB9APOLB
SCHEMBL1485752 0.75 MAPT (0.70) MAPTHTTALDH1A1MEN1GAA
SCHEMBL2256877 0.74 MAPT (0.67) MAPTHTTALDH1A1HRH3L3MBTL1
SCHEMBL19635836 0.73 MAPT (0.40) MAPTHTTALDH1A1MEN1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120168693-A1 SILVER-(CONJUGATED COMPOUND) COMPOSITE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-07-05 US disclosed
US-20120032121-A1 METALLIC COMPOSITE AND COMPOSITION THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120032121-A1 METALLIC COMPOSITE AND COMPOSITION THEREOF CDH1, EPCAM, CD4 MAPT 297/4885HTT 3725/4885ALDH1A1 932/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.